NCT00129038View on ClinicalTrials.gov

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 1, 2004

Primary Completion Date

January 1, 2007

Conditions
Coronary Arteriosclerosis
Interventions
DRUG

modified-release dipyridamole/aspirin

DRUG

aspirin

Trial Locations (2)

Unknown

9.169.01 Dept of Clinical Pharmacology, Dublin

9.169.02 St. James' Hospital, Dublin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00129038 - Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients | Biotech Hunter | Biotech Hunter